Tiziana Cauli, Author at CannIntelligence

Charlotte’s Web teams up with BAT to seek approval for new hemp-based drug

Written by Tiziana Cauli || 12th April 2023 || News analysis |

British American Tobacco (BAT) and cannabis wellness company Charlotte’s Web have formed a joint venture to pursue approval for a new hemp-based drug to target an undisclosed neurological condition ...

Tobacco giant Altria considers cannabis for its non-nicotine product offering

Written by Tiziana Cauli || 31st March 2023 || News analysis |

Altria is considering including cannabis as well as caffeine pouches in its offering of non-nicotine products as part of its growth strategy ...

Spannabis: a celebration of the cannabis sector despite lingering uncertainties

Written by Tiziana Cauli || 14th March 2023 || Blogs |

Business representatives and scientists from across the globe gathered in Barcelona last week for a series of international events dedicated to the world of legal cannabis ...

US DEA draws a ‘clear line in the sand’ on synthetically derived THCO acetates

Written by Tiziana Cauli || 21st February 2023 || News analysis |

The US Drug Enforcement Administration (DEA) has clarified its position on two synthetic hemp derivatives, confirming that it considers delta-8 THCO and delta-9 THCO illegal ...

Twitter announces changes to its cannabis ad policy, but what’s changed?

Written by Tiziana Cauli || 17th February 2023 || News analysis |

Twitter’s recently announced “change” in the social media platform’s policy to allow cannabis advertisements in the US is full of sound but signifies nothing ...

CBD brands apply for certification as Google lifts ads ban in some parts of US

Written by Tiziana Cauli || 10th February 2023 || News analysis |

Cannabis companies are looking to get Google certification as part of the tech giant’s update on the use of Google Ads for CBD products in parts of the US ...

EFSA denies waiting to follow US FDA’s lead on CBD safety in novel foods

Written by Tiziana Cauli || 1st February 2023 || News analysis |

The European Food Safety Authority denies it is waiting research results on the safety of CBD by the US Food and Drug Administration before it lets validated candidates complete the novel food application process ...

US FDA issues guidance for development of cannabis-based medical drugs

Written by Tiziana Cauli || 27th January 2023 || News analysis |

The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis ...

US FDA says lack of evidence for dietary-supplement pathway to CBD regulation

Written by Tiziana Cauli || 26th January 2023 || News analysis |

The US Food and Drug Administration (FDA) has rejected a regulatory pathway that would allow CBD products to be treated as food additives or dietary supplements ...

Developing countries could get economic boost from industrial hemp, says UN

Written by Tiziana Cauli || 25th January 2023 || News analysis |

Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status ...

Aussie approval puts Chanelle McCoy on the way toward OTC sleeping aid sales

Written by Tiziana Cauli || 19th January 2023 || News analysis |

CBD company Chanelle McCoy Health has received approval to start a trial which may allow it to sell its CBD sleeping aid as an over-the-counter (OTC) drug in Australian pharmacies ...

FDA expected to issue recommendation ‘soon’ on CBD regulation in the US

Written by Tiziana Cauli || 13th January 2023 || News analysis |

The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country ...

Poll finds cannabis now twice as popular as tobacco smoking with young US adults

Written by Tiziana Cauli || 4th January 2023 || News analysis |

Young adults in the US are giving up on cigarettes and alcohol as their consumption of cannabis outgrows that of tobacco and may be behind a dip in alcohol sales in some states ...

US FDA again issues warning letters on CBD in ingestibles, this time with a twist

Written by Tiziana Cauli || 30th December 2022 || News analysis |

The FDA has made clear for years that CBD in food is illegal in the US, as it violates the Federal Food, Drug, and Cosmetic (FD&C) Act. What’s different this...

US teens’ use of cannabis and other illicit substances still less than pre-pandemic

Written by Tiziana Cauli || 27th December 2022 || News analysis |

The use of illicit substances, including cannabis, by US teenagers has plateaued in 2022 after a significant decline in 2021, a national survey found ...

Tobacco giant invests $57m as Charlotte’s Web continues to spin its net wider

Written by Tiziana Cauli || 1st December 2022 || News analysis |

British American Tobacco (BAT) has invested nearly $57m in Charlotte’s Web, as the Colorado, US-based CBD maker keeps broadening the spectrum of its partnerships ...

EIHA’s ‘reasonable daily intake’ sows confusion over novel food applications

Written by Tiziana Cauli || 17th November 2022 || News analysis |

CBD isolate producers in the UK are waiting to see whether and how toxicological data released by the European Industrial Hemp Association (EIHA) will affect their novel food applications to the Food Standards Agency (FSA) ...

More validated but no light at the end of the tunnel for Efsa’s novel food applicants

Written by Tiziana Cauli || 16th November 2022 || News analysis |

Nearly six months after the European Food Safety Authority (Efsa) put novel food assessments for cannabinoids on hold, none of the validated applicants has been able to fill the identified knowledge gaps ...

CannIntelligence meets the stars at the World CBD awards in Barcelona

Written by Tiziana Cauli || 16th November 2022 || Blogs |

CannIntelligence was among the participants at the recent World CBD Awards show in Barcelona. Check out our red carpet video for a fuller flavour of what happened on the night ...

Cannabis consumption up, cigarette smoking down in latest US Gallup poll

Written by Tiziana Cauli || 18th October 2022 || News analysis |

Smoking cigarettes is going out of fashion, but having smoked cannabis is becoming much more common in the US, according to recent research conducted by analytics and polling firm Gallup ...

Authors of UK hemp farming report respond to criticisms of impossible goals

Written by Tiziana Cauli || 14th October 2022 || News analysis |

The creators of a UK report on hemp that has received criticism from the industry told CBD-Intel they stand by their estimates, but it remains unclear where some of the numbers have come from ...

Tobacco giant deepens its interest in cannabis with cash for German firm

Written by Tiziana Cauli || 29th September 2022 || News analysis |

Tobacco giant British American Tobacco (BAT) has again bet on the cannabis industry as it looks to diversify its portfolio ...

HHC and other intoxicating cannabinoids move within legal limbo in Europe

Written by Tiziana Cauli || 16th September 2022 || News analysis |

As debate over the legalisation of recreational cannabis involves a growing number of European countries, the commercial demand for legal psychoactive alternatives to controlled cannabinoid variants is on the rise ...

New B2B platform will aim to make cannabinoids ‘boring’ and reliable

Written by Tiziana Cauli || 24th August 2022 || News analysis |

A new online trading platform will soon facilitate B2B CBD transactions within the EU, filling a gap the company behind it says has so far remained almost unbridged ...

US House agriculture committee hears wish list of changes to 2023 Farm Bill

Written by Tiziana Cauli || 12th August 2022 || News analysis |

A group of US Congress members, state agriculture commissioners, researchers and industry representatives told a Congressional committee what changes to the law they would include in the upcoming 2023 Farm Bill if given the chance ...

Spain’s first medical cannabis regulation could boost sector despite restrictions

Written by Tiziana Cauli || 29th July 2022 || News analysis |

Patients in Spain will soon be able to access cannabis in pharmacies with a medical prescription as the government is about to introduce new legislation ...

CBD and cannabis on Australia’s horizon – but don’t thank Labor government

Written by Tiziana Cauli || 25th July 2022 || News analysis |

CBD products may start to appear on the Australian market but it will not be due to any action taken by the newly elected Labor government, according to industry insiders and experts ...

Report calls for cannabis product testing to be standardised between US states

Written by Tiziana Cauli || 20th July 2022 || News analysis |

A US coalition of lawyers and lab researchers has called for the implementation of national standards in the testing of cannabis products ...

Data gaps in EU novel food applications will be difficult, slow and costly to fill

Written by Tiziana Cauli || 15th June 2022 || News analysis |

CBD companies say they do not know when or even how they will be able to provide the missing data that has caused the European Food Safety Authority (EFSA) to pause the clock on assessing novel food applications...

State bank regulators call for America Competes to incorporate SAFE Act

Written by Tiziana Cauli || 13th June 2022 || News analysis |

US state bank regulators have asked Congress to provide legal cannabis businesses with access to financial services by integrating a bill preventing banks from being penalised for doing so into a broader law on innovation and competition ...

Australian companies looking to sell CBD treatments online with prescriptions

Written by Tiziana Cauli || 8th June 2022 || News analysis |

Companies are trying new ways to reach cannabinoid customers in severely restricted Australia, but they must be careful not to fall foul of strict guidelines that separate promoting from simply informing the public about prescription goods ...

EFSA puts novel food assessment on hold for applicants to provide missing data

Written by Tiziana Cauli || 7th June 2022 || News analysis |

A hold has been placed on European novel food assessment after the European Food Safety Authority (EFSA) said it was unable to proceed due to identified knowledge gaps in safety data ...

FDA sends warnings to companies selling CBD-containing veterinary products

Written by Tiziana Cauli || 1st June 2022 || News analysis |

The US Food and Drug Administration (FDA) has issued warnings to four companies that have sold veterinary products containing CBD ...

EU officially recognises first CBG-rich hemp variety among registered plants

Written by Tiziana Cauli || 13th May 2022 || News analysis |

The EU has granted official recognition to a hemp variety rich in cannabigerol (CBG) by including a new cannabinoid strain in its database of registered plant varieties ...

DEA defines cannabis seeds with less than 0.3% THC as hemp and as legal

Written by Tiziana Cauli || 2nd May 2022 || News analysis |

The US Drug Enforcement Administration (DEA) has confirmed that cannabis seeds fall outside the realm of the Controlled Substances Act (CSA) – regardless of how much THC the plant could eventually yield ...

Industry bodies optimistic UK regulators will take Hodges Review on board

Written by Tiziana Cauli || 20th April 2022 || News analysis |

Industry associations hope a review of UK policy on cannabinoids will help the government address regulation that has limited the development of the CBD and wider sectors ...

UK broadcaster Channel 4 puts its weight behind Cannaray and the CBD market

Written by Tiziana Cauli || 12th April 2022 || News analysis |

UK public service TV network Channel 4 believes the country’s CBD market will continue to grow and has backed its position by investing in the Cannaray brand ...

US FDA warns CBD firms over fraudulent and ‘life-threatening’ Covid claims

Written by Tiziana Cauli || 5th April 2022 || News analysis |

The US Food and Drug Administration (FDA) has issued warning letters to seven CBD companies for claiming that some of the products they sell may be used to prevent or cure Covid-19 ...

LATEST ALERTS